α1-Adrenoceptors in the rat cerebral cortex: New insights into the characterization of α1L- and α1D-adrenoceptors

European Journal of Pharmacology

Volumn 641, Issue 1, 2010, Pages 41-48

  Segura, Vanessa ^a   Flacco, Nicla ^a   Oliver, Eduardo ^a   Barettino, Domingo ^b   D'Ocon, Pilar ^a   Ivorra, Maria Dolores ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

Author keywords

1 Adrenoceptor subtype; 1D Intracellular localization; 1L Adenoceptor; 3H prazosin binding study; G protein; Rat cerebral cortex

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; ALPHA 1L ADRENERGIC RECEPTOR; GUANYLYLIMIDODIPHOSPHATE; INOSITOL PHOSPHATE; MESSENGER RNA; NORADRENALIN; PRAZOSIN; UNCLASSIFIED DRUG; ADRENERGIC RECEPTOR ALPHA(1D); ADRENERGIC RECEPTOR ALPHA(1L); GUANOSINE TRIPHOSPHATE;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; BRAIN CORTEX; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOLIC FRACTION; FEMALE; IMMUNOBLOTTING; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RADIOASSAY; RAT; REAL TIME POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; TISSUE HOMOGENATE; ANIMAL; BINDING COMPETITION; CHEMISTRY; CYTOLOGY; CYTOSOL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WISTAR RAT;

ANIMALS; BINDING, COMPETITIVE; CELL MEMBRANE; CEREBRAL CORTEX; CYTOSOL; FEMALE; GENE EXPRESSION REGULATION; GUANOSINE TRIPHOSPHATE; INOSITOL PHOSPHATES; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77953809054     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.05.016     Document Type: Article

References (44)

1. Alexander, S.P., Mathie, A., Peters, J.A., 2008. Guide to Receptors and Channels (GRAC), 3rd edition. Br. J. Pharmacol. 153 Suppl 2:S1-209.
2. Amobi N.I., Guillebaud J., Kaisary A.V., Turner E., Smith I.C. Discrimination by SZL49 between contractions evoked by noradrenaline in longitudinal and circular muscle of human vas deferens. Br. J. Pharmacol. 2002, 136:127-135.
3. Argyle S.A., McGrath J.C. An alpha(1A)/alpha(1L)-adrenoceptor mediates contraction of canine subcutaneous resistance arteries. J. Pharmacol. Exp. Ther. 2000, 295:627-633.
4. Berridge M.J., Dawson R.M., Downes C.P., Heslop J.P., Irvine R.F. Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem. J. 1983, 212:473-482.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
6. Chalothorn D., McCune D.F., Edelmann S.E., Garcia-Cazarin M.L., Tsujimoto G., Piascik M.T. Differences in the cellular localization and agonist-mediated internalization properties of the alpha(1)-adrenoceptor subtypes. Mol. Pharmacol. 2002, 61:1008-1016.
7. Cheng Y., Prusoff W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22:3099-3108.
8. Day H.E., Campeau S., Watson S.J., Akil H. Distribution of alpha 1a-, alpha 1b- and alpha 1d-adrenergic receptor mRNA in the rat brain and spinal cord. J. Chem. Neuroanat. 1997, 13:115-139.
9. de Ligt R.A., Kourounakis A.P., IJzerman A.P. Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery. Br. J. Pharmacol. 2000, 130:1-12.
10. Deighan C., Woollhead A.M., Colston J.F., McGrath J.C. Hepatocytes from alpha1B-adrenoceptor knockout mice reveal compensatory adrenoceptor subtype substitution. Br. J. Pharmacol. 2004, 142:1031-1037.
11. Ford A.P., Arredondo N.F., Blue D.R., Bonhaus D.W., Jasper J., Kava M.S., Lesnick J., Pfister J.R., Shieh I.A., Vimont R.L., Williams T.J., McNeal J.E., Stamey T.A., Clarke D.E. RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification. Mol. Pharmacol. 1996, 49:209-215.
12. Ford A.P., Daniels D.V., Chang D.J., Gever J.R., Jasper J.R., Lesnick J.D., Clarke D.E. Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification. Br. J. Pharmacol. 1997, 121:1127-1135.
13. Gray K., Short J., Ventura S. The alpha1A-adrenoceptor gene is required for the alpha1L-adrenoceptor-mediated response in isolated preparations of the mouse prostate. Br. J. Pharmacol. 2008, 155:103-109.
14. Hiraizumi-Hiraoka Y., Tanaka T., Yamamoto H., Suzuki F., Muramatsu I. Identification of alpha-1L adrenoceptor in rabbit ear artery. J. Pharmacol. Exp. Ther. 2004, 310:995-1002.
15. Hiraoka Y., Ohmura T., Oshita M., Watanabe Y., Morikawa K., Nagata O., Kato H., Taniguchi T., Muramatsu I. Binding and functional characterization of alpha1-adrenoceptor subtypes in the rat prostate. Eur. J. Pharmacol. 1999, 366:119-126.
16. Hirasawa A., Sugawara T., Awaji T., Tsumaya K., Ito H., Tsujimoto G. Subtype-specific differences in subcellular localization of alpha1-adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface alpha1-adrenoceptors irrespective of the subtype. Mol. Pharmacol. 1997, 52:764-770.
17. Kenakin T. Principles: receptor theory in pharmacology. Trends Pharmacol. Sci. 2004, 25:186-192.
18. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
19. Leff P., Dougall I.G. Further concerns over Cheng-Prusoff analysis. Trends Pharmacol. Sci. 1993, 14:110-112.
20. Madrero Y., Elorriaga M., Martinez S., Noguera M.A., Cassels B.K., D'Ocon P., Ivorra M.D. A possible structural determinant of selectivity of boldine and derivatives for the alpha 1A-adrenoceptor subtype. Br. J. Pharmacol. 1996, 119:1563-1568.
21. Marti D., Miquel R., Ziani K., Gisbert R., Ivorra M.D., Anselmi E., Moreno L., Villagrasa V., Barettino D., D'Ocon P. Correlation between mRNA levels and functional role of alpha1-adrenoceptor subtypes in arteries: evidence of alpha1L as a functional isoform of the alpha1A-adrenoceptor. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H1923-H1932.
22. McCune D.F., Edelmann S.E., Olges J.R., Post G.R., Waldrop B.A., Waugh D.J., Perez D.M., Piascik M.T. Regulation of the cellular localization and signaling properties of the alpha(1B)- and alpha(1D)-adrenoceptors by agonists and inverse agonists. Mol. Pharmacol. 2000, 57:659-666.
23. Michel M.C., Buscher R., Kerker J., Kraneis H., Erdbrugger W., Brodde O.E. Alpha 1-adrenoceptor subtype affinities of drugs for the treatment of prostatic hypertrophy. Evidence for heterogeneity of chloroethylclonidine-resistant rat renal alpha 1-adrenoceptor. Naunyn-Schmiedebergs Arch. Pharmacol. 1993, 348:385-395.
24. Michel M.C., Kenny B., Schwinn D.A. Classification of alpha 1-adrenoceptor subtypes. Naunyn-Schmiedebergs Arch. Pharmacol. 1995, 352:1-10.
25. Morishima S., Tanaka T., Yamamoto H., Suzuki F., Akino H., Yokoyama O., Muramatsu I. Identification of alpha-1L and alpha-1A adrenoceptors in human prostate by tissue segment binding. J. Urol. 2007, 177:377-381.
26. Morishima S., Suzuki F., Yoshiki H., Md Anisuzzaman A.S., Sathi Z.S., Tanaka T., Muramatsu I. Identification of the alpha1L-adrenoceptor in rat cerebral cortex and possible relationship between alpha1L- and alpha1A-adrenoceptors. Br. J. Pharmacol. 2008, 153:1485-1494.
27. Morris D.P., Price R.R., Smith M.P., Lei B., Schwinn D.A. Cellular trafficking of human alpha1a-adrenergic receptors is continuous and primarily agonist-independent. Mol. Pharmacol. 2004, 66:843-854.
28. Muramatsu I., Morishima S., Suzuki F., Yoshiki H., Anisuzzaman A.S., Tanaka T., Rodrigo M.C., Myagmar B.E., Simpson P.C. Identification of alpha 1L-adrenoceptor in mice and its abolition by alpha 1A-adrenoceptor gene knockout. Br. J. Pharmacol. 2008, 155:1224-1234.
29. Ohmura T., Muramatsu I. Two distinct alpha 1-adrenoceptor subtypes in rabbit liver: a binding study. Br. J. Pharmacol. 1995, 116:2591-2596.
30. Ohmura T., Oshita M., Kigoshi S., Muramatsu I. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies. Br. J. Pharmacol. 1992, 107:697-704.
31. Oliver E., Marti D., Monto F., Flacco N., Moreno L., Barettino D., Ivorra M.D., D'Ocon P. The impact of alpha1-adrenoceptors up-regulation accompanied by the impairment of beta-adrenergic vasodilatation in hypertension. J. Pharmacol. Exp. Ther. 2009, 328:982-990.
32. Oshita M., Kigoshi S., Muramatsu I. Three distinct binding sites for [3H]-prazosin in the rat cerebral cortex. Br. J. Pharmacol. 1991, 104:961-965.
33. Pennefather J.N., Lau W.A., Chin C., Story M.E., Ventura S. alpha(1L)-adrenoceptors mediate noradrenaline-induced contractions of the guinea-pig prostate stroma. Eur. J. Pharmacol. 1999, 384:25-30.
34. Pruitt K.D., Maglott D.R. RefSeq and LocusLink: NCBI gene-centered resources. Nucleic Acids Res. 2001, 29:137-140.
35. Saussy D.L., Goetz A.S., Queen K.L., King H.K., Lutz M.W., Rimele T.J. Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype. J. Pharmacol. Exp. Ther. 1996, 278:136-144.
36. Schwinn D.A., Johnston G.I., Page S.O., Mosley M.J., Wilson K.H., Worman N.P., Campbell S., Fidock M.D., Furness L.M., Parry-Smith D.J. Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues. J. Pharmacol. Exp. Ther. 1995, 272:134-142.
37. Scofield M.A., Liu F., Abel P.W., Jeffries W.B. Quantification of steady state expression of mRNA for alpha-1 adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction. J. Pharmacol. Exp. Ther. 1995, 275:1035-1042.
38. Stam W.B., Van der Graaf P.H., Saxena P.R. Analysis of alpha 1L-adrenoceptor pharmacology in rat small mesenteric artery. Br. J. Pharmacol. 1999, 127:661-670.
39. Stanasila L., Abuin L., Dey J., Cotecchia S. Different internalization properties of the alpha1a- and alpha1b-adrenergic receptor subtypes: the potential role of receptor interaction with beta-arrestins and AP50. Mol. Pharmacol. 2008, 74:562-573.
40. Su T.H., Morishima S., Suzuki F., Yoshiki H., Anisuzzaman A.S., Tanaka T., Cheng J.T., Muramatsu I. Native profiles of alpha(1A)-adrenoceptor phenotypes in rabbit prostate. Br. J. Pharmacol. 2008, 155:906-912.
41. Suzuki F., Taniguchi T., Nakamura S., Akagi Y., Kubota C., Satoh M., Muramatsu I. Distribution of alpha-1 adrenoceptor subtypes in RNA and protein in rabbit eyes. Br. J. Pharmacol. 2002, 135:600-608.
42. Theroux T.L., Esbenshade T.A., Peavy R.D., Minneman K.P. Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. Mol. Pharmacol. 1996, 50:1376-1387.
43. Van der Graaf P.H., Deplanne V., Duquenne C., Angel I. Analysis of alpha1-adrenoceptors in rabbit lower urinary tract and mesenteric artery. Eur. J. Pharmacol. 1997, 327:25-32.
44. Yang M., Verfurth F., Buscher R., Michel M.C. Is alpha1D-adrenoceptor protein detectable in rat tissues?. Naunyn-Schmiedebergs Arch. Pharmacol. 1997, 355:438-446.